Concepedia

Author

Kay Ka-Wai Li

Chinese University of Hong Kong

Also Known As

Kay Ka-Wai Li

12

Publications

417

Citations

8

H-Index

22

Concepts

All Affiliations

Chinese University of Hong KongHuashan HospitalFudan UniversityChinese University of Hong Kong, ShenzhenPrince of Wales Hospital
KK

About

Kay Ka-Wai Li is an author at Chinese University of Hong Kong specializing in pathology, glioma, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

281

2

Pathology

5

5

281

3

Health Sciences

1

1

116

4

Cell Biology

1

1

60

5

Neurology

1

1

27

Kay Ka-Wai Li

×

8

Publications

406

Citations

8

H-Index

YearCitations

TERT promoter mutations contribute to subset prognostication of lower-grade gliomas

Aden Ka‐Yin Chan, Yu Yao, Zhenyu Zhang,

Modern Pathology

2014

116

Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors

Aden Ka‐Yin Chan, Jesse Chung‐Sean Pang, Nellie Yuk-Fei Chung,

Modern Pathology

2013

60

Pediatric low-grade gliomas can be molecularly stratified for risk

Rui Yang, Abudumijiti Aibaidula, Weiwei Wang,

Acta Neuropathologica

2018

53

Combination genetic signature stratifies lower-grade gliomas better than histological grade

Aden Ka‐Yin Chan, Yu Yao, Zhenyu Zhang,

Oncotarget

2015

50

Biomarker-based prognostic stratification of young adult glioblastoma

Rui-qi Zhang, Zhifeng Shi, Hong Chen,

Oncotarget

2015

49

Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic

Yan-Xi Li, Zhifeng Shi, Abudumijiti Aibaidula,

Oncotarget

2016

27

Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation

Rui Zhang, Sherri Huang, Kay Ka-Wai Li,

Oncotarget

2017

26

Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy

Zhenyu Zhang, Jian Xu, Yong Ren,

PLoS ONE

2014

25

Page 1